Drug Type CIK therapy |
Synonyms- |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), CIK cells replacements(Cytokine-induced killer cells replacements) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | 23 May 2016 |